Role & Responsibilities of Authorized Agent for Drugs in India
The role of authorized agent responsibilities is critical for foreign Pharmaceutical companies seeking to register, Import, and market Drugs in India while ensuring full regulatory compliance with CDSCO requirements. An authorized agent acts as the legal representative in India, bridging communication between the foreign manufacturer and Indian regulatory authorities throughout […]
Read MoreDocuments Required for Cosmetic Import License in India (Checklist 2026)
The Central Drugs Standard Control Organization (CDSCO) is responsible for issuing Cosmetic Import licenses in India. Importers must apply through the SUGAM portal using Form COS-1 for fresh products. After successful evaluation, CDSCO grants the registration certificate in Form COS-2. The approval timeline is approximately 180 working days, and the […]
Read MoreRegulatory Due Diligence for Medical Devices in India: What Manufacturers Must Know Before Market Entry
Regulatory Due Diligence for Medical Devices in India is essential for manufacturers planning to enter the country’s rapidly growing healthcare market. Proper regulatory assessment ensures compliance with CDSCO guidelines, licensing requirements, device classification rules, and safety standards. India has strengthened its regulatory framework under the Medical Device Rules (MDR), 2017, […]
Read More
How to Get a CDSCO Import License in India: A Step-by-Step Guide for Foreign Medical Device Companies
In India given its large population and ample growth opportunities, remains one of the most attractive markets for global Medical Devices company. But entering Indian market is not so easy as it not only involves commercial decision— but also involves defining correct regulatory pathway The Central Drugs Standard Control Organisation […]
Read More
How to Apply for BIS Certification in India: Process, Documents & Timeline
Businesses planning to apply BIS certification India must understand the regulatory framework governed by the Bureau of Indian Standards. The BIS certification process ensures product quality, safety, and compliance with national standards before entering the Indian market. Manufacturers and importers often need BIS approval for regulated products such as electronics, […]
Read More
Regulatory Pathway for Biologicals in India: Approval Process & Key Requirements
The Regulatory Pathway for Biologicals in India is governed by strict guidelines to ensure the safety, efficacy, and quality of biological products. Manufacturers must follow regulatory frameworks established by CDSCO and the Ministry of Health before market entry. Biological products such as vaccines, monoclonal antibodies, and recombinant therapeutics require extensive […]
Read MoreRegulation/Guidelines
Pharmacovigilance Regulations For Imported Drugs In India
Pharmacovigilance ensures that Drugs are continuously monitored for safety, quality, and efficacy through structured reporting systems and regulatory oversight mechanisms post-approval. In India, the pharmacovigilance regulations for imported drugs are overseen by CDSCO. India’s regulatory authority, CDSCO, mandates stringent Pharmacovigilance practices to detect, assess, and prevent adverse Drug reactions, thereby […]
Regulation/Guidelines
Inappropriate Use of Artificial Intelligence in Pharmaceutical Manufacturing
Artificial intelligence in pharmaceutical manufacturing can help support quality control, decision-making, process monitoring, batch evaluation, and data management by analysing complex production data to improve efficiency and product consistency. However, its use also introduces risks such as poor data quality, privacy concerns, regulatory challenges, lack of transparency, and high implementation […]
Regulation/Guidelines
AI in Pharma Industry: Boon or Bane
Artificial Intelligence is reshaping the Pharmaceutical industry by enhancing research efficiency, accelerating Drug development, and improving data-driven decision-making. However, its use also raises concerns related to privacy, bias, and regulatory compliance. While AI offers significant benefits across the drug lifecycle, its safe and ethical application depends on strong governance, transparency, […]